Literature DB >> 2101674

The effect of tamoxifen on cervical squamous maturation in Papanicolaou stained cervical smears of post-menopausal women.

T P Eells1, H D Alpern, C Grzywacz, R W MacMillan, J E Olson.   

Abstract

Using cervical smears obtained as part of routine gynaecological examinations, a retrospective study of the effects of the drug tamoxifen on squamous epithelial maturation of the cervix of post-menopausal women being treated for advanced breast cancer was made. The degree of squamous epithelial maturation was quantitated by using the Maturation Index and the Maturation Value. Although tamoxifen is a synthetic, non-steroidal compound classified as anti-oestrogenic, the findings indicate that this drug commonly produces a level of squamous maturation indicative of oestrogenic stimulation in Papanicolaou stained cervical smears from post-menopausal patients receiving this drug. Knowledge of the oestrogenic effect of tamoxifen in the cervix can obviate clinical concern about endometrial carcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2101674     DOI: 10.1111/j.1365-2303.1990.tb00359.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  5 in total

1.  Gynaecological effects of tamoxifen.

Authors:  S M Ismail
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

2.  Pathology of endometrium treated with tamoxifen.

Authors:  S M Ismail
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

Review 3.  Gynaecologic effects of tamoxifen.

Authors:  D Y Kuo; C D Runowicz
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

Review 4.  Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.

Authors:  Kin-Mang Lau; Ka-Fai To
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

5.  Challenges of Managing Lower Urinary Tract Symptoms in Women with Tamoxifen Use.

Authors:  Ethan M Fan; Philippe E Zimmern
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.